Let’s Talk About Diabetes Tech, Intimacy, and Type 1: The Conversations We’re Not Having
26 August 2025

Let’s Talk About Diabetes Tech, Intimacy, and Type 1: The Conversations We’re Not Having

Within Range: Demystifying Diabetes Tech for Healthcare Professionals

About

In this special episode of Within Range, recorded live in Amsterdam at ATTD, host Cindy Pickering, Clinical Services Manager at Insulet, sits down with the team behind the podcast Typecast: Life Between the Lines to explore a topic that’s deeply personal, and too often overlooked in diabetes care: intimacy.

Cindy is joined by:

    Natalie Balmain – Omnipod Ambassador, activist, and host of TypecastAmanda Epps – Diabetes Specialist Nurse and researcher on diabetes tech and intimacyTimothy Jenkinson (aka Grace Shush) – Drag artist and diabetes advocate


Together, they bring decades of lived experience with Type 1 diabetes to a raw, funny, and vital conversation. From CGMs falling off in the bedroom to confidence in dating, fear of judgment, and why healthcare professionals rarely raise the issue, this episode doesn’t shy away from the realities of managing diabetes and maintaining intimacy.

They discuss:

    Why conversations around sex and diabetes tech are often absent in clinicThe emotional and physical challenges of navigating intimacy with visible techHow gender norms and toxic masculinity affect tech use and confidenceThe role of peer support and social media in filling the education gapSimple ways HCPs can open up the conversation without fear or shame

 

(This episode was recorded live at Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam.)

Note: The information in this podcast is accurate to the date of recording as of 03/20/2025. Amanda Epps received a fee from Insulet for taking part in this Podcast, views and opinions Amanda expresses in this podcast are her own and do not necessarily reflect those of Insulet. This Podcast is meant for healthcare professionals to better understand the Omnipod 5 System and its use within clinical practice settings. Omnipod 5 is CE Marked, UKCA marked, Health Canada approved, and TGA approved for use in Type 1 diabetes in people ages 2 years and up. For a complete description of Omnipod 5 including indications, contraindications and important safety information for the UK please visit: https://www.omnipod.com/en-gb/safety For other regions, please refer to country specific statements at www.omnipod.comOmnipod 5 may not be available in your country.

 

    INS-OHS-07-2025-00358 v1.0